Neuroectodermal Tumors, Primitive, Peripheral - 14 Studies Found Completed : BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. : Pancreatic Neuroendocrine Tumors (pNET) : 2012-07-06 : Drug: BEZ235 (Stage 1) The investigational study drug used in this trial was BEZ235, which was supplied Active, not recruiting : Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET) : Metastatic Medulloblastoma High Risk Supratentorial PNET < : 2012-02-27 : Drug: Carboplatin Administered Completed : IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor : Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Biological: cixutumumab Given Completed : High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood : Medulloblastoma Brain Tumors Neuroectodermal Tumors, Primi : 2005-09-09 : Drug: Etoposide, carboplatin, melphalan, cisplatin, thiotepa Completed : Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma : Sarcoma : 1999-11-01 : Biological: filgrastim Drug: busulfan Completed : Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer : Kidney Cancer Sarcoma : 1999-11-01 : Drug: cyclophosphamide Drug: doxorubicin h Terminated : Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET : Islet Cell Tumor : 2011-06-14 : Drug: Everolimus Everolimus wa Terminated : Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors : Pancreatic Neuroendocrine Tumors (pNET) : 2012-06-25 : Drug: BEZ235 BEZ235 400 mg bid Recruiting : International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma : Brain Tumors : 2014-02-07 : Radiation: Radiotherapy without Carboplatin Terminated : Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs : Gliomas Medulloblastoma Neuroectodermal Tumors, Primitive< : 2014-10-20 : Biological: Vaccine (autologous dendritic cells) Next >>>
